Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
WRAIR-PAM-CF1 is a bacteriophage-based therapeutic agent currently being in ongoing trials investigated as a non-traditional antimicrobial solution for the treatment of multidrug-resistant Pseudomonas aeruginosa infections. Bacteriophage-based therapeutics mean using viruses that specifically target and kill bacterial pathogens
see also:
Pseudomonas aeruginosa infections & Drugs/Treatments
…